Improvement of efficacy in Crohn's disease by early use of infliximab
Not Applicable
Recruiting
- Conditions
- Crohn's disease
- Registration Number
- JPRN-UMIN000020335
- Lead Sponsor
- IBD Relapse Prevention Team
- Brief Summary
1) Chiba M et al. Induction with infliximab and a plant-based diet as first-line (IPF) therapy for Crohn disease: A Single-group trial. Perm J 2017;21:17-009 2) Chiba M et al. How to avoid primary non-responders to infliximab in Crohn's disease. Inflamm Bowel Dis 2017;23:E55-E56 3) Chiba M et al. Relapse-free course in nearly half of Crohn's disease patients with infliximab and plant-based diet as first-line (IPF) therapy: Single-group trial. Perm J 2022;26:21.073
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patient who was initially treated by steroid or immunosuppressants
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method